# Access HBV Assays - European Union (EU) Clinical Trial Protocol -

> **NCT04904835** · — · COMPLETED · sponsor: **Beckman Coulter, Inc.** · enrollment: 21210 (actual)

## Conditions studied

- HBV

## Interventions

- **DIAGNOSTIC_TEST:** Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays

## Key facts

- **NCT ID:** NCT04904835
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-15
- **Primary completion:** 2025-12-09
- **Final completion:** 2026-03-05
- **Target enrollment:** 21210 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904835, "Access HBV Assays - European Union (EU) Clinical Trial Protocol -". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04904835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*